Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
27.18
+1.56 (+6.09%)
Official Closing Price
Updated: 7:00 PM EDT, May 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pfizer
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Pfizer (PFE) Q1 2024 Earnings Call Transcript
Today 18:30 EDT
PFE earnings call for the period ending March 31, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Why Pfizer Stock Blasted More Than 6% Higher Today
Today 17:55 EDT
A double beat on earnings, plus raised bottom-line guidance, made the company a hot item on Hump Day.
Via
The Motley Fool
Dow Jumps 200 Points Following Fed Decision; Pfizer Earnings Top Estimates
Today 14:32 EDT
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
PFE Stock Earnings: Pfizer Beats EPS, Beats Revenue for Q1 2024
Today 10:52 EDT
PFE stock results show that Pfizer beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Pfizer Q1 Earnings and Revenues Beat Estimates
Today 10:40 EDT
PFE came out with quarterly earnings of $0.82 per share, beating the our eimate of $0.56 per share. This compares to earnings of $1.23 per share a year ago.
Via
Talk Markets
Pfizer Embraces Direct-To-Consumer Model For Covid Antiviral, Says Comirnaty Revenues Continue To Perform Consistently With Expectations
Today 10:38 EDT
Pfizer reports Q1 results: adjusted EPS beats estimates, driven by revenue growth. Significant declines in Comirnaty and Paxlovid revenues countered by operational gains. Company announces plans for...
Via
Benzinga
Exposures
COVID-19
(PFE) - Analyzing Pfizer's Short Interest
April 30, 2024
Via
Benzinga
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
April 29, 2024
With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
US Stocks Mixed Ahead Of Fed Meeting, Chipmakers Tumble After AMD Earnings, Bitcoin Sinks: What's Driving Markets Wednesday?
Today 13:07 EDT
Traders are treading cautiously in Wednesday’s session, seeking more clarity on the Federal Reserve’s stance with inflation reports exceeding expectations.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
Today 9:42 EDT
Discover GSK's first-quarter performance, boasting a 10% Y/Y sales surge to £7.4 billion. Notable growth in Vaccines and Specialty Medicines, propelled by strong demand for Arexvy and Shingrix....
Via
Benzinga
Pfizer Jumps After Raising Its Outlook On The Heels Of A Big Quarterly Beat
Today 8:50 EDT
The company raised its earnings outlook for the year, noting it's on track to save at least $4 billion in net costs.
Via
Investor's Business Daily
Pfizer Reports First-Quarter 2024 Results
Today 6:45 EDT
From
Pfizer Inc.
Via
Business Wire
Wall Street Set To Open Lower After AMD Earnings Disappoint As Traders Look To Fed's Powell For Relief: Why This Analyst Sees Incoming Summer Rally
Today 6:44 EDT
A negative sentiment might linger on Wall Street on Wednesday, as evidenced by stock futures, after Advanced Micro Devices, Inc.‘s (NASDAQ:AMD)
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Investor Sentiment Falls, Dow Snaps Five-Month Win Streak
Today 3:42 EDT
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Amazon, Pfizer And 3 Stocks To Watch Heading Into Wednesday
Today 3:42 EDT
Via
Benzinga
7 Safe Haven Stocks That Can Withstand the Market’s Worst Meltdowns
April 30, 2024
Safe haven stocks offer stability even during market fall in communication, financials, healthcare, energy and consumer staples.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
April 30, 2024
Via
Benzinga
Pfizer Sees Less Revenue From Covid-19 Treatments, Stock Faces Headwinds Ahead Of Q1 Earnings
April 30, 2024
Pfizer's Q1 earnings report expects EPS of 49 cents and $13.09 billion in revenues. Stock has declined 34.61% YoY and -10.94% YTD due to COVID-19 revenue decrease. Technical analysis shows bearish...
Via
Benzinga
Exposures
COVID-19
5 Top Stocks to Buy in May
April 30, 2024
Whether you're looking for a proven player, passive income, or a breakout growth story, there are plenty of stocks worth buying this spring.
Via
The Motley Fool
Why I'm Buying This Beaten-Down, High-Yield Dividend Stock Hand Over Fist
April 30, 2024
The sun could be peeking through the dark clouds for Pfizer.
Via
The Motley Fool
Forget Nvidia: Prominent Billionaires Are Selling It and Buying These 2 Ultra-High-Yield Dividend Stocks Instead
April 30, 2024
Wall Street's brightest, most successful billionaire money managers are ditching Nvidia in favor of two time-tested income stocks with yields of 6.6%!
Via
The Motley Fool
TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer
April 29, 2024
From
Genmab A/S
Via
Business Wire
FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer
April 29, 2024
From
Pfizer Inc.
Via
Business Wire
mRNA Is Promising A Breakthrough In Fighting Cancer
April 29, 2024
When it comes to cancer, there’s innovation both on the diagnostics and the treatment front thanks to messenger RNA, or mRNA, a genetic material we all got acquainted with during the COVID-19 era as it...
Via
Benzinga
Exposures
COVID-19
3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot Pole
April 29, 2024
These stocks aren't bargains.
Via
The Motley Fool
Pfizer Highlights Progress in Accelerating Breakthrough Cancer Medicines at ASCO 2024 Annual Meeting
April 29, 2024
From
Pfizer Inc.
Via
Business Wire
3 Dividend Stocks to Buy on the Dip: April 2024
April 29, 2024
With the market presenting many vagaries, investors may take some solace in these dividend stocks to buy on the dip.
Via
InvestorPlace
Is Viking Therapeutics Incredibly Undervalued?
April 28, 2024
The biotech's weight loss drug candidate could fuel a premium-laden buyout, but risks abound.
Via
The Motley Fool
3 High-Yield Dividend Stocks That Could Soar 22% to 49%, According to Wall Street
April 28, 2024
Whether or not these stocks hit analysts' price targets, they all should be attractive to investors seeking great income and solid growth.
Via
The Motley Fool
3 Dividend Stocks to Buy and Hold for the Next Decade
April 27, 2024
You'll get dividends and more with these great stocks.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.